Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gosney

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Histopathology|December 30, 2014
Morphological and genetic classification of lung cancer: variation in practice and implications for tailored treatmentPaul Cane, Karen M Linklater, Andrew G Nicholson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 18, 2012
Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patientsMichael Poullis, James McShane, Mathew Shaw, et al.
Respiratory Research|January 12, 2017
Whole Transcriptome Analysis of Pre-invasive and Invasive Early Squamous Lung Carcinoma in Archival Laser Microdissected SamplesAndre Koper, Leo A H Zeef, Leena Joseph, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment RegimenMerdol Ibrahim, Suzanne Parry, Dawn Wilkinson, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2020
International real-world study of DLL3 expression in patients with small cell lung cancerFederico Rojo, Marcelo Corassa, Dimitrios Mavroudis, et al.
British Journal of Cancer|September 7, 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary PathologistsColin R Lindsay, Emily C Shaw, David A Moore, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
Human Molecular Genetics|August 18, 2012
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controlsMaria N Timofeeva, Rayjean J Hung, Thorunn Rafnar, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Histopathology|December 30, 2014
Morphological and genetic classification of lung cancer: variation in practice and implications for tailored treatmentPaul Cane, Karen M Linklater, Andrew G Nicholson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 18, 2012
Smoking status at diagnosis and histology type as determinants of long-term outcomes of lung cancer patientsMichael Poullis, James McShane, Mathew Shaw, et al.
Respiratory Research|January 12, 2017
Whole Transcriptome Analysis of Pre-invasive and Invasive Early Squamous Lung Carcinoma in Archival Laser Microdissected SamplesAndre Koper, Leo A H Zeef, Leena Joseph, et al.
Lung Cancer (Amsterdam, Netherlands)|February 4, 2025
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancerPaul Hofman, Petros Christopoulos, Nicky D'Haene, et al.
Histopathology|May 20, 2016
PD-L1 testing for lung cancer in the UK: recognizing the challenges for implementationIan A Cree, Richard Booton, Paul Cane, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2016
ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment RegimenMerdol Ibrahim, Suzanne Parry, Dawn Wilkinson, et al.
Lung Cancer (Amsterdam, Netherlands)|August 4, 2020
International real-world study of DLL3 expression in patients with small cell lung cancerFederico Rojo, Marcelo Corassa, Dimitrios Mavroudis, et al.
British Journal of Cancer|September 7, 2021
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary PathologistsColin R Lindsay, Emily C Shaw, David A Moore, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
Human Molecular Genetics|August 18, 2012
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controlsMaria N Timofeeva, Rayjean J Hung, Thorunn Rafnar, et al.
Pageof 3